Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201106364 Principal Investigator: Wang-Gillam, Andrea
Title: A Phase 2, Randomized, Multicenter, Open-Label, Study of the Efficacy and Immune Response of the Sequential Administration of GVAX Pancreas Vaccine (with Cyclophosphamide) Alone or Followed by CRS 207 in Adults with Metastatic Pancreatic Adenocarcinoma
Phase: II Disease Site: Pancreas
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to determine whether the study drugs are safe and effective in patients with advanced pancreatic cancer. The drugs to be tested in this study are GVAX pancreas vaccine with low doses of cyclophosphamide and CRS-207.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)